Senores Pharmaceuticals Limited — Updates, 20-01-2026: Press Release
20-01-2026 | 02:16 pm
20-01-2026 | 02:16 pm
Senores Pharma delivered strong latest quarter results: Income surged 64% to Rs. 175 Cr, and PAT jumped 105% to Rs. 34 Cr. The Apnar Pharma acquisition integration is ahead of schedule, with 3 ANDAs launching soon. Emerging Markets achieved record revenue and profitability.
No comments yet. Be the first to comment!
